MS

Mahantesh S Patil

Active Director Designated Partner DIN 10414752
DIN 10414752 First appointment Dec 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahantesh S Patil

Data last updated:

Mahantesh S Patil is a Designated Partner at Sansmed Lifescience Llp (since 2023). The company operates in Business Services.

DIN 10414752
Primary Designation Designated Partner
Industry Business Services
First Appointment 04 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Dec 20232023Active

Board colleagues of Mahantesh S Patil

NameDINCompanyDesignation
Elamittath Prabhakara Menon Santhosh07950625Sansmed Lifescience LlpDesignated Partner
Varsha06740981Sansmed Lifescience LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sansmed Lifescience Llp
Premium access

Shareholding and investment profile for Mahantesh S Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahantesh S Patil

Mahantesh S Patil currently holds 1 directorship: Sansmed Lifescience Llp (Designated Partner, since 04 Dec 2023).

Mahantesh S Patil was first appointed on 04 Dec 2023 as Designated Partner at Sansmed Lifescience Llp.

The current boards of Mahantesh S Patil's companies include Elamittath Prabhakara Menon Santhosh (Sansmed Lifescience Llp), Varsha (Sansmed Lifescience Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available